Med

Med is a premier peer-reviewed journal published by Cell Press, a leading imprint of Elsevier, dedicated to advancing translational and clinical medicine. With an ISSN of 2666-6340 and an abbreviation of MED-CAMBRIDGE, the journal holds a distinguished position in the field, evidenced by its 2026 Impact Factor of 13.3000 and its placement in the top tier (JCR Quartile Q1). The journal’s scope encompasses the full spectrum of medical research, from fundamental discoveries at the bench to the development of novel therapies and their implementation at the bedside. It particularly emphasizes studies that bridge the gap between laboratory science and clinical application, including precision medicine, disease mechanisms, biomarker discovery, and therapeutic interventions across all medical specialties. Med publishes a diverse array of article types, including original research articles, comprehensive reviews, perspectives, and clinical trials, as well as shorter formats such as reports and commentaries that highlight urgent findings. The target audience is broad yet specialized, comprising clinical researchers, physician-scientists, translational investigators, and healthcare professionals seeking high-impact, actionable insights. A notable feature of Med is its hybrid open access model, allowing authors to choose open access publication to maximize global dissemination. The journal’s rigorous editorial standards and Q1 status underscore its influence as a leading forum for transformative medical science, making it a vital resource for those at the forefront of translating biological understanding into tangible improvements in human health.